5-硝基-2-茚酮 | 116530-60-0

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 中文名称: 5-硝基-2-茚酮
• 中文别名: 5-硝基-2-茚满酮
• 英文名称: 5-nitro-2-indanone
• 英文别名: 5-nitro-1,3-dihydro-2H-inden-2-one；5-nitroindan-2-one；5-nitro-1,3-dihydroinden-2-one
• CAS: 116530-60-0
• 化学式: C₉H₇NO₃
• mdl: MFCD00598938
• 分子量: 177.159
• InChiKey: VSEBFWRYDORZJI-UHFFFAOYSA-N

物化性质

• 沸点：
  340.6±42.0 °C(Predicted)
• 密度：
  1.396±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  62.9
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 安全说明：
  S26
• 危险类别码：
  R36/37/38
• 海关编码：
  2914700090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温下应存于干燥密封的容器中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Nitro-2-indanone
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Nitro-2-indanone
CAS number: 116530-60-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H7NO3
Molecular weight: 177.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

5-硝基-2-茚酮是一种医药中间体，可通过以下两种方法制备：一是从2-茚醇经过四步反应得到；二是先对茚进行硝化反应，再进行氧化反应。

反应信息

• 作为反应物：
  描述：

  5-硝基-2-茚酮 在 palladium 10% on activated carbon 氢气 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 5.5h， 生成 N,N-dimethyl-5-nitro-2,3-dihydro-1H-inden-2-amine
  参考文献：
  名称：

  [EN] TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
  [FR] COMPOSÉS DE TRIAZOLE QUI MODULENT L'ACTIVITÉ DE LA HSP90

  摘要：

  公开号：

  WO2007139955A3
• 作为产物：
  描述：

  2-茚醇 在 吡啶 、 水 、 硝酸 、 戴斯-马丁氧化剂 、 三氟乙酸 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 24.0h， 生成 5-硝基-2-茚酮
  参考文献：
  名称：

  一类茚满-5-甲酰胺RORγ调节剂及其用途

  摘要：

  本发明涉及结构如式(I)所示的化合物或其立体异构体、互变异构体或其药学上可接受的盐或其溶剂合物或者前药、其制备方法、含有这些调节剂的药物组合物及其在治疗RORγ介导的炎性、代谢性和自身免疫性疾病中的用途。

  公开号：

  CN109384711A

文献信息

• [EN] HETEROCYCLIC COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET PROCÉDÉS D'UTILISATION
  申请人：MEDIVATION TECHNOLOGIES INC

  公开号：WO2015058084A1

  公开（公告）日：2015-04-23

  The present application discloses compounds that are inhibitors of Btk, compounds that are inhibitors of ΡΒΚδ, and compounds that are dual inhibitors of both Btk and PI3Kδ. Also described are methods for synthesizing such inhibitors and methods for using such inhibitors for the treatment of diseases wherein inhibition of Btk and PI3Kδ provides a therapeutic benefit to a patient having the disease.

  本申请公开了抑制Btk的化合物、抑制ΡΒΚδ的化合物，以及既是Btk又是PI3Kδ的双重抑制剂的化合物。还描述了合成这些抑制剂的方法，以及利用这些抑制剂治疗疾病的方法，其中抑制Btk和PI3Kδ对患有该疾病的患者提供治疗益处。
• [EN] IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION<br/>[FR] IMIDAZOPYRIDINES UTILISÉES COMME NOUVEL ÉCHAFAUDAGE POUR L'INHIBITION DES KINASES À CIBLES MULTIPLES
  申请人：ABBOTT LAB

  公开号：WO2011053476A1

  公开（公告）日：2011-05-05

  Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula (I).

  抑制蛋白激酶的化合物，含有这些化合物的组合物以及使用这些化合物治疗疾病的方法被披露。公式（I）。
• [EN] 1, 2 - DIHYDRO- 3H- PYRAZOLO [3, 4 - D] PYRIMIDIN -3 - ONE ANALOGS<br/>[FR] ANALOGUES DE 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE
  申请人：ZENO ROYALTIES & MILESTONES LLC

  公开号：WO2019028008A1

  公开（公告）日：2019-02-07

  Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.

  本文提供了式（I）的化合物。这些化合物以及其药学上可接受的盐和组合物对于治疗疾病或症状是有用的，包括那些以细胞过度增殖为特征的病症，比如乳腺癌。
• [EN] QUINAZOLINONE DERIVATIVES<br/>[FR] DERIVES DE QUINAZOLINONE
  申请人：CELLTECH R&D LTD

  公开号：WO2004022554A1

  公开（公告）日：2004-03-18

  A compound of formula (1), wherein: X is an oxygen or sulfur atom; R1 is an aliphatic, cycloaliphatic or cycloalkyl-alkyl- group; R2 is an optionally substituted heteroaromatic group or a -CN group; R3 is a group -(Alk1)mL1(AIk2)nR4 in which m and n, which may be the same or different, is each zero or the integer 1, Alk1 and AIk2, which may be the same or different, is each an optionally substituted aliphatic or heteroaliphatic chain, L1 is a covalent bond or a linker atom or group and R4 is a hydrogen atom or an optionally substituted cycloaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group; A is an optionally substituted cycloaliphatic or heterocycloaliphatic group optionally fused to an optionally substituted aryl or heteroaryl group; R5, which may be attached to any available C or N atom present in the cycloaliphatic or heterocycloaliphatic, or where fused, aryl or heteroaryl group, is a group -(AIk3)tL2(AIk4)vR6 in which t and v, which may be the same or different, is each zero or the integer 1, Alk3 and AIk4, which may be the same or different, is each an optionally substituted aliphatic or heteroaliphatic chain, L2 is a covalent bond or a linker atom or group and R6 is a hydrogen or halogen atom or a -CN group or an optionally substituted cycloaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group; and the salts, solvates, hydrates, tautomers, isomers or N-oxides thereof. The compounds of the present invention are potent inhibitors of IMPDH.

  式（1）的化合物，其中：X是氧原子或硫原子；R1是脂肪族、环脂族或环烷基-烷基基团；R2是可选择取代的杂芳基团或一个-CN基团；R3是一个组-(Alk1)mL1(AIk2)nR4，其中m和n，可以相同也可以不同，每个都是零或整数1，Alk1和AIk2，可以相同也可以不同，每个都是可选择取代的脂肪族或杂脂族链，L1是一个共价键或连接原子或基团，R4是氢原子或可选择取代的环脂族、杂环脂族、芳香族或杂芳族基团；A是一个可选择取代的环脂族或杂环脂族基团，可选择与一个可选择取代的芳基或杂芳基团融合；R5，可以连接到环脂族或杂环脂族中任何可用的C或N原子，或者融合的芳基或杂芳基团，是一个组-(AIk3)tL2(AIk4)vR6，其中t和v，可以相同也可以不同，每个都是零或整数1，Alk3和AIk4，可以相同也可以不同，每个都是可选择取代的脂肪族或杂脂族链，L2是一个共价键或连接原子或基团，R6是氢原子或卤素原子或一个-CN基团或可选择取代的环脂族、杂环脂族、芳香族或杂芳族基团；以及其盐、溶剂合物、水合物、互变异构体、异构体或N-氧化物。本发明的化合物是IMPDH的有效抑制剂。
• SUBSTITUTED P-PHENYLENEDIAMINES AS NEW OXIDATION DYE PRECURSOR PRODUCTS OF THE DEVELOPER TYPE
  申请人：Henkel AG & Co. KGaA

  公开号：US20170165166A1

  公开（公告）日：2017-06-15

  Compounds, and agents for oxidatively changing the color of keratinic fibers that include such compounds, in particular human hair, in a cosmetic carrier. The compounds are at least one oxidation dye precursor product of formula (I) and/or physiologically acceptable salt thereof, in which R1, R2, R3, R4 independently of one another, stand for a hydrogen atom, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, a hydroxy-(C 1 -C 6 )-alkyl group, a polyhydroxy-(C 2 -C 6 )-alkyl group, or a C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl group, n stands for an integer from 2 to 6, and Z stands for an aromatic or aliphatic heterocycle or for an aromatic or aliphatic carbocycle.

  这段文字的中文翻译如下： 化合物和氧化性改变角蛋白纤维颜色的药剂，包括这些化合物，特别是人类头发，在化妆品载体中。这些化合物至少是一种化学式(I)的氧化染料前体产品和/或其生理上可接受的盐，其中R1、R2、R3、R4分别独立地代表氢原子、C1-C6烷基、C2-C6烯基、羟基-(C1-C6)-烷基、多羟基-(C2-C6)-烷基或C1-C6-烷氧基-C2-C6-烷基，n代表一个从2到6的整数，Z代表芳香或脂肪杂环或芳香或脂肪碳环。